Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirong Peng

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Translational Oncology|June 12, 2022
The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastomaJingxia Tang, Shirong Peng, Haifeng Yan, et al.
Medicine|November 13, 2024
Fuzheng-Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysisXiao Liang, Shirong Peng, Hai Huang, et al.
Journal of Translational Medicine|May 5, 2023
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasionZean Li, Yiran Tao, Ze Gao, et al.
World Journal of Urology|September 23, 2025
The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacologyBingliang Chen, Zhen He, Shirong Peng, et al.
APL Bioengineering|November 28, 2022
Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancerShirong Peng, Xinyu Zhang, Hao Huang, et al.
Frontiers in Cell and Developmental Biology|September 7, 2021
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate CancerQiong Wang, Wanhua Wu, Ze Gao, et al.
Future Medicinal Chemistry|December 17, 2019
Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methodsKaiwen Li, Zean Li, Yiran Tao, et al.
ACS Biomaterials Science & Engineering|June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer TherapyShunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Frontiers in Cell and Developmental Biology|November 4, 2021
Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell CarcinomaZe Gao, Junxiu Chen, Yiran Tao, et al.
Neuroscience|February 24, 2025
Hippocampal P2X4 receptor induces type 1 diabetes rats with neuropathic pain through microglial-derived neuroinflammation and neuronal damageXuanwei Zhang, Wenyu Zhang, Yan Li, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Translational Oncology|June 12, 2022
The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastomaJingxia Tang, Shirong Peng, Haifeng Yan, et al.
Medicine|November 13, 2024
Fuzheng-Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysisXiao Liang, Shirong Peng, Hai Huang, et al.
Journal of Translational Medicine|May 5, 2023
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasionZean Li, Yiran Tao, Ze Gao, et al.
World Journal of Urology|September 23, 2025
The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacologyBingliang Chen, Zhen He, Shirong Peng, et al.
APL Bioengineering|November 28, 2022
Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancerShirong Peng, Xinyu Zhang, Hao Huang, et al.
Frontiers in Cell and Developmental Biology|September 7, 2021
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate CancerQiong Wang, Wanhua Wu, Ze Gao, et al.
Future Medicinal Chemistry|December 17, 2019
Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methodsKaiwen Li, Zean Li, Yiran Tao, et al.
ACS Biomaterials Science & Engineering|June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer TherapyShunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Frontiers in Cell and Developmental Biology|November 4, 2021
Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell CarcinomaZe Gao, Junxiu Chen, Yiran Tao, et al.
Neuroscience|February 24, 2025
Hippocampal P2X4 receptor induces type 1 diabetes rats with neuropathic pain through microglial-derived neuroinflammation and neuronal damageXuanwei Zhang, Wenyu Zhang, Yan Li, et al.
Pageof 3